Management of primary and metastatic malignant small bowel obstruction, operate or palliate. A systematic review

被引:12
作者
Banting, Samuel P. [1 ]
Waters, Peadar S. [1 ]
Peacock, Oliver [1 ]
Narasimhan, Vignesh [1 ]
Lynch, Andrew C. [1 ]
McCormick, Jacob J. [1 ]
Warrier, Satish K. [1 ]
Heriot, Alexander G. [1 ]
机构
[1] Peter MacCallum Canc Ctr, Surg Oncol, Colorectal Surg Unit, 305 Grattan St, Melbourne, Vic 3000, Australia
关键词
colorectal malignancy; decompression; gynaecological malignancy; malignant small bowel obstruction; palliative surgery; small bowel obstruction; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; ADVANCED CANCER-PATIENTS; INTESTINAL-OBSTRUCTION; OVARIAN-CANCER; TUBE PLACEMENT; SURGERY; DECOMPRESSION; SURVIVAL; EFFICACY; CARCINOMATOSIS;
D O I
10.1111/ans.16188
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background The management of patients presenting with malignant small bowel obstruction is a challenging paradigm. The aim of this systematic review was to examine different management strategies in these complex patients. The primary outcomes evaluated were the type of intervention, 30-day morbidity and mortality and overall survival rates. Methods A systematic literature review of EMBase, Medline, PubMed and the Cochrane Library was performed using Preferred Reporting Items for Systematic reviews and Meta-Analyses for studies reporting on conservative and operative management of malignant small bowel obstruction. Results Fifteen studies (n= 882 patients) reporting on outcomes for malignant small bowel obstruction were analysed. Outcomes measured were primarily survival and relief of obstructive symptoms. The median age ranged from 52 to 66 years. The most common cause of malignant small bowel obstruction was gynaecological in nature (56%), followed by colorectal (19%). Four hundred and eighty-six patients underwent primary surgical management and the remaining 396 patients were assigned to non-surgical intervention. Median overall survival in the operative studies ranged from 2.5 to 7.4 months compared with 0.9 to 1.9 months (P < 0.05). The 30-day mortality ranged from 13% to 28% in those who underwent surgical interventions versus 2% to 61% in the non-surgical group (P= 0.09). No significant difference in median survival in gastrointestinal (GI) and gynaecological malignancies was observed (4.3 versus 5.0 months,P= 0.12). Morbidity ranged from 21% to 85% in the surgical group and 12% to 29% in the percutaneous groups (P < 0.05). Conclusion Surgical intervention in malignant small bowel obstruction is associated with significant morbidity, although it may improve survival in selected patients with gynaecological and colorectal malignancy. It is imperative that realistic goals and expectations are discussed with patients preoperatively.
引用
收藏
页码:282 / 290
页数:9
相关论文
共 43 条
  • [1] Abbas SM, 2007, WORLD J SURG ONCOL, V5, P4
  • [2] Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer
    Blair, SL
    Chu, DZJ
    Schwarz, RE
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (08) : 632 - 637
  • [3] Quality of life and length of survival in advanced cancer patients on home parenteral nutrition
    Bozzetti, F
    Cozzaglio, L
    Biganzoli, E
    Chiavenna, G
    De Cicco, M
    Donati, D
    Gilli, G
    Percolla, S
    Pironi, L
    [J]. CLINICAL NUTRITION, 2002, 21 (04) : 281 - 288
  • [4] An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancer
    Bryan, DN
    Radbod, R
    Berek, JS
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (01) : 125 - 134
  • [5] Palliative treatment of upper intestinal obstruction by gynecological malignancy: The usefulness of percutaneous endoscopic gastrostomy
    Campagnutta, E
    Cannizzaro, R
    Gallo, A
    Zarrelli, A
    Valentini, M
    DeCicco, M
    Scarabelli, C
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 62 (01) : 103 - 105
  • [6] Digital Image Processing of Palm Oil Fruits
    Choong, Thomas S. Y.
    Abbas, Saad
    Shariff, Abdul Rashid
    Halim, Rohaya
    Ismail, Mohd Halim S.
    Yunus, Robiah
    Ali, Salmiaton
    Ahmadun, Fakhrul-Razi
    [J]. INTERNATIONAL JOURNAL OF FOOD ENGINEERING, 2006, 2 (02)
  • [7] Double-Blind, Placebo-Controlled, Randomized Trial of Octreotide in Malignant Bowel Obstruction
    Currow, David C.
    Quinn, Stephen
    Agar, Meera
    Fazekas, Belinda
    Hardy, Janet
    McCaffrey, Nikki
    Eckermann, Simon
    Abernethy, Amy P.
    Clark, Katherine
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 49 (05) : 814 - 821
  • [8] Palliative care in patients with ovarian cancer and bowel obstruction
    Daniele, Alberto
    Ferrero, A.
    Fuso, L.
    Mineccia, M.
    Porcellana, V.
    Vassallo, D.
    Biglia, N.
    Menato, G.
    [J]. SUPPORTIVE CARE IN CANCER, 2015, 23 (11) : 3157 - 3163
  • [9] Benefits and risks of a percutaneous endoscopic gastrostomy (PEG) for decompression in patients with malignant gastrointestinal obstruction
    Dittrich, Anne
    Schubert, Barbara
    Kramer, Michael
    Lenz, Felicitas
    Kast, Karin
    Schuler, Ulrich
    Schuler, Markus K.
    [J]. SUPPORTIVE CARE IN CANCER, 2017, 25 (09) : 2849 - 2856
  • [10] Parenteral nutrition prolongs the survival of patients associated with malignant gastrointestinal obstruction
    Fan, Bo-Guang
    [J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2007, 31 (06) : 508 - 510